Fabien B. Vincent

Research Fellow; Rheumatology Research Group, Centre for Inflammatory Diseases, Monash University

Dr. Vincent is a physician-scientist currently employed as a research fellow in the rheumatology group, centre for inflammatory diseases at Monash University.

He completed his medical training, including advanced training in rheumatology, at the University Hospital Centre of Caen and Paris in France between 1999 and 2010. He completed his PhD in immunology at Monash University in Melbourne between 2012 and 2018.

Dr. Vincent's specialization is in rheumatology with a focus on autoimmunity, specifically molecular and B cell immunology, and biomarker development in systemic lupus erythematosus. Dr. Vincent has a strong interest in Indigenous Australian health research.

Experience

  • 2016–present
    Research Fellow, Rheumatology Research Group, Centre for Inflammatory Diseases, Monash University
  • 1999–2010
    Medical Training, University Hospital Center (CHU) of Caen and Paris, France

Education

  • 2018 
    Monash University, Melbourne, Australia, PhD in Immunology
  • 2011 
    University of Paris-Sud XI, France, Master in Sciences – Immunology, with high honours
  • 2010 
    University of Medicine, Caen, France, M.D., Rheumatology board certified
  • 2010 
    University of Medicine, Paris and Lille, France, Degree in Polyarthritis and Autoimmune Disease
  • 2010 
    University of Medicine, Caen, France, Master in Clinical Research, with high honours
  • 2009 
    University of Medicine, Nantes, France, Degree in interventional rheumatology
  • 2002 
    University of Medicine, Caen, France, Degree in Cytopathology and Immunopathology
  • 1999 
    Dumont D’Urville High School, Caen, France, High school degree in science, with honors

Publications

  • 2013
    Vincent FB et al. Clinical associations of serum interleukin-17 in systemic lupus erythematosus. , Arthritis Res Ther 2013
  • 2013
    Vincent et al. Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralizing agents in chronic inflammatory diseases: a real issue, a clinical perspective., Ann Rheum Dis 2013;72:165-78
  • 2013
    Vincent FB et al. Focus on systemic lupus erythematosus in Indigenous Australians: toward a better understanding of autoimmune diseases., Intern Med J 2013;43:227-34
  • 2013
    Vincent FB et al. The BAFF/APRIL system: emerging functions beyond B cell biology and autoimmunity, Cytokine Growth Factor Rev 2013; 24:29-40
  • 2013
    Murielle M, Henri P, Vincent FB et al. Mesangial immunoglobulin (Ig)A glomerulonephritis in a patient with rheumatoid arthritis treated with abatacept., Joint Bone Spine 2013; doi:10.1016/j.jbspin.2013.05.003
  • 2013
    Figgett WA, Fairfax K, Vincent FB et al. TACI regulates Tindependent marginal zone B cell responses through innate activation-induced cell death., Immunity 2013
  • 2013
    Vincent FB et al. Association of serum B cell activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosus., Lupus 2013
  • 2012
    Vincent et al. BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus, Immunol Cell Biol 2012;90(3):293-303.

Grants and Contracts

  • 2019
    Identification of molecular signatures in Indigenous Australians with systemic lupus erythematosus
    Role:
    CIA
    Funding Source:
    Rebecca L. Cooper Medical Research Foundation

Research Areas

  • Rheumatology And Arthritis (110322)
  • Immunology (1107)
  • Applied Immunology (Incl. Antibody Engineering, Xenotransplantation And T Cell Therapies) (110702)
  • Autoimmunity (110703)
  • Sports Medicine (110604)
  • Innate Immunity (110707)